Which of the following is Bruton's tyrosine Kinase inhibitor ?: (A) Gilteritinib, (B) Axitinib, (C) Ibrutinib, (D) Bosutinib
Answer is C. Ibrutinib is a Bruton's tyrosine Kinase inhibitor that inhibits porliferation of B-cells. It is used in the treatment of CLL, Waldenstorm macroglobulinemia.